Cardio Diagnostics (CDIO)

• Market cap: $22.2M
• 1 day: -1.50%
• 5 days: -8.26%
• 1 month: -13.68%
• 3 months: -56.48%
• 6 months: 70.64%
• Year to date: -51.19%
• 1 year: -68.40%
• 5 years: -88.83%
• 10 years: -88.83%
• Sector: Healthcare
• Industry: In Vitro & In Vivo Diagnostic Substances

About: Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.

Employees: 9

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

530% more capital invested

Capital invested by funds: $374K [Q3] → $2.35M (+$1.98M) [Q4]

53% more funds holding

Funds holding: 15 [Q3] → 23 (+8) [Q4]

0.13% less ownership

Funds ownership: 6.48% [Q3] → 6.36% (-0.13%) [Q4]